Adam S Grossman insider trades

Open-market stock purchases and sales by Adam S Grossman, President and CEO at Adma Biologics, Inc, from SEC Form 4 filings since Feb 13, 2012.

Track record: 100% of 48 scored buys are up 5% or more since purchase, averaging +75%.

Recent trades

DateStockTradeValue
Mar 16, 2026ADMA Adma Biologics, IncSold$227K
Mar 16, 2026ADMA Adma Biologics, IncSold$91K
Mar 16, 2026ADMA Adma Biologics, IncBought (not open market)—
Mar 7, 2026ADMA Adma Biologics, IncSold (not open market)$454K
Mar 6, 2026ADMA Adma Biologics, IncSold (not open market)$869K
Feb 26, 2026ADMA Adma Biologics, IncSold (not open market)$833K
Feb 19, 2026ADMA Adma Biologics, IncSold (not open market)$405K
Feb 17, 2026ADMA Adma Biologics, IncSold$241K
Feb 17, 2026ADMA Adma Biologics, IncSold$96.5K
Feb 17, 2026ADMA Adma Biologics, IncBought (not open market)—
Feb 9, 2026ADMA Adma Biologics, IncBought (not open market)—
Feb 9, 2026ADMA Adma Biologics, IncBought (not open market)—
Dec 15, 2025ADMA Adma Biologics, IncSold$297K
Dec 15, 2025ADMA Adma Biologics, IncSold$119K
Dec 15, 2025ADMA Adma Biologics, IncBought (not open market)—
Nov 19, 2025ADMA Adma Biologics, IncSold$240K
Nov 19, 2025ADMA Adma Biologics, IncSold$96K
Nov 19, 2025ADMA Adma Biologics, IncBought (not open market)—
Oct 24, 2025ADMA Adma Biologics, IncSold$240K
Oct 24, 2025ADMA Adma Biologics, IncSold$96K
Oct 24, 2025ADMA Adma Biologics, IncBought (not open market)—

Companies traded

  • ADMA Adma Biologics, Inc: 52 buys, 31 sales, last Mar 16, 2026
  • NONE R&R Acquisition VI, Inc: other filings, last Feb 13, 2012

Get free alerts when Adam S Grossman files a new trade →